• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.

作者信息

Lee S C, Fung C P, Liu P Y, Wang T C, See L C, Lee N, Chen S C, Shieh W B

机构信息

Division of Infectious Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.

出版信息

Infect Control Hosp Epidemiol. 1999 Mar;20(3):205-7. doi: 10.1086/501614.

DOI:10.1086/501614
PMID:10100550
Abstract

Prospective studies were conducted for nosocomial Pseudomonas aeruginosa infections from February 1, 1994, to October 30, 1995. Of 97 P. aeruginosa isolates from 97 patients, 35 were resistant to ceftazidime. Logistic regression revealed previous cephalosporin or piperacillin use as independent risk factors for nosocomial ceftazidime-resistant P. aeruginosa infection. Pulsed-field gel electrophoresis revealed that four nosocomial ceftazidime-resistant P. aeruginosa infections were caused by cross-infection, probably through medical personnel.

摘要

相似文献

1
Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.
Infect Control Hosp Epidemiol. 1999 Mar;20(3):205-7. doi: 10.1086/501614.
2
Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.产金属β-内酰胺酶铜绿假单胞菌的医院感染:分子流行病学、危险因素、临床特征及转归
J Hosp Infect. 2014 Aug;87(4):234-40. doi: 10.1016/j.jhin.2014.05.007. Epub 2014 Jun 20.
3
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.在台湾一所大学医院引发医院感染的泛耐药铜绿假单胞菌
Clin Microbiol Infect. 2005 Aug;11(8):670-3. doi: 10.1111/j.1469-0691.2005.01196.x.
4
Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.巴西南部医院中产生SPM-1样和IMP-1样金属β-内酰胺酶的铜绿假单胞菌的传播
Infection. 2007 Dec;35(6):457-60. doi: 10.1007/s15010-007-6289-3. Epub 2007 Nov 21.
5
Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.台湾某教学医院中多重耐药铜绿假单胞菌菌血症的抗菌治疗与控制
J Microbiol Immunol Infect. 2008 Dec;41(6):491-8.
6
Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.土耳其马拉蒂亚市一家大学医院铜绿假单胞菌感染的临床、微生物学和流行病学特征
Am J Infect Control. 2006 May;34(4):188-92. doi: 10.1016/j.ajic.2005.11.010.
7
Controlling the clonal spread of Pseudomonas aeruginosa infection.控制铜绿假单胞菌感染的克隆传播。
Infect Control Hosp Epidemiol. 2008 Jun;29(6):549-52. doi: 10.1086/588163.
8
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.铜绿假单胞菌菌血症患者死亡的危险因素:抗菌药物耐药性对预后的临床影响。
Microb Drug Resist. 2011 Jun;17(2):305-12. doi: 10.1089/mdr.2010.0170. Epub 2011 Mar 7.
9
[Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].[2002年至2006年期间法国一家大学医院对铜绿假单胞菌抗菌药物耐药性的演变]
Pathol Biol (Paris). 2010 Feb;58(1):1-6. doi: 10.1016/j.patbio.2009.08.002. Epub 2009 Oct 28.
10
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.医院获得性多重耐药铜绿假单胞菌感染的危险因素及临床结局
J Hosp Infect. 2004 Jun;57(2):112-8. doi: 10.1016/j.jhin.2004.03.021.

引用本文的文献

1
Economic and human burden attributable to antimicrobial resistance in Spain: a holistic macro-estimation of costs.西班牙抗菌药物耐药性所致的经济和人力负担:成本的整体宏观估算
Eur J Health Econ. 2024 Dec 21. doi: 10.1007/s10198-024-01746-3.
2
Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa.铜绿假单胞菌所致医院感染患者抗生素耐药危险因素评估
Can J Infect Dis Med Microbiol. 2016;2016:1321487. doi: 10.1155/2016/1321487. Epub 2016 Aug 30.
3
Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study.
外科手术患者 ICU 住院期间多重耐药革兰氏阴性菌感染:一项队列研究。
Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):557-66. doi: 10.1007/s10096-011-1347-2. Epub 2011 Jul 28.
4
Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.抗假单胞菌药物对重症内科患者铜绿假单胞菌定植及耐药性获得的影响
Intensive Care Med. 2009 Mar;35(3):439-47. doi: 10.1007/s00134-008-1326-y. Epub 2008 Oct 21.
5
Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections.局部递送的多克隆抗体可增强静脉注射抗生素对革兰氏阴性菌感染的疗效。
Pharm Res. 2002 Dec;19(12):1801-7. doi: 10.1023/a:1021481122011.
6
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.亚胺培南的使用与铜绿假单胞菌的β-内酰胺耐药性相关。
Antimicrob Agents Chemother. 2002 Sep;46(9):2920-5. doi: 10.1128/AAC.46.9.2920-2925.2002.